fundraising
NOX
Offer Open
Noxopharm Raises $1.5 Million to Accelerate Clinical Programs
Biotech firm Noxopharm has secured $1.5 million via a placement and announced plans for a $1.0 million SPP.
November 4, 2026
Share:

Biotechnology company Noxopharm has successfully raised $1.5 million through a placement to propel its SOF-SKN clinical program. In addition to the placement, the company plans to launch a $1.0 million Share Purchase Plan (SPP) and has converted $3.78 million in notes to further accelerate its drug development pipeline.
Capital Raise
Biotech
Noxopharm

